Ghrelin improves dystonia and tremor in patients with Rett syndrome: A pilot study.
J Neurol Sci
; 377: 219-223, 2017 Jun 15.
Article
em En
| MEDLINE
| ID: mdl-28477699
ABSTRACT
BACKGROUND:
Dystonia occurs in approximately 60% of patients with Rett syndrome (RTT) and severely impairs their quality of life. However, an effective standard therapy has not been established. In a previous study, ghrelin levels were significantly decreased in patients with RTT, in particular, among patients over 10years old. This prompted speculation that ghrelin may play an important role in RTT.OBJECTIVES:
Four patients, including two adults, with severe dystonia and tremor, were recruited.METHODS:
Ghrelin was intravenously administered at a dose of 3µg/kg, once-daily for 3days, followed by once every 3weeks. Objective evaluation was performed, including scoring for different clinical features (SDCF), the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the Visual Analog Scale (VAS).RESULTS:
The SDCF, BFMDRS, autonomic dysfunction and VAS scores were markedly improved in two patients with severe dystonia and head tremor.CONCLUSION:
Ghrelin may improve extrapyramidal symptoms in patients with RTT.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tremor
/
Síndrome de Rett
/
Distonia
/
Grelina
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article